Compare Cassava Sciences Inc (FLNA) vs Alliant Energy Corporation (LNT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cassava Sciences Inc vs Alliant Energy Corporation — how do they compare? Cassava Sciences Inc trades at $0.82 (market cap $39.40M), while Alliant Energy Corporation trades at $65.55 (market cap $16.99B). The key difference: Alliant Energy Corporation is far larger — about 431.2× Cassava Sciences Inc's market cap, and Alliant Energy Corporation pays a 3.27% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Cassava Sciences Inc for 37 Days and Alliant Energy Corporation for 64 Days on average.
| FLNA | LNT | |
|---|---|---|
Market Cap | $39.40M | $16.99B |
Volume | 759,018 | 2,488,387 |
Sector | Health | Utilities |
52-Week High | $4.64 | $78.03 |
52-Week Low | $0.68 | $63.21 |
Typical Hold Time | 37 Days | 64 Days |
Enterprise Value | -$43.28M | $29.08B |
Dividend Yield | — | 3.27% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FLNA trades at $0.8157, down 6.77% today, with a bearish technical signal from moving averages. The company shows improving quarterly EPS trends, beating expectations in recent quarters, though it remains unprofitable with negative ROE and ROA. Recent FDA clearance for its epilepsy drug trial provides a positive catalyst. Analyst sentiment is bullish with 67% buy ratings.
The outlook hinges on clinical progress; upside exists if Phase 2a trials succeed, but high cash burn and lack of revenue pose significant risks. Investors should weigh the strong analyst support against the company's financial challenges and binary clinical outcomes.
LNT trades at $65.21, down 0.43% on the day, with a bullish technical signal despite mixed indicators. The company shows strong fundamentals with revenue growth to $4.36B in 2025 and net income of $810M, beating earnings estimates in three consecutive quarters. Analyst consensus is positive with a $77 price target and no sell ratings among 23 analysts. Recent news highlights institutional buying and a $13.4B capital investment plan supporting long-term growth.
LNT presents a favorable investment case with stable utility operations, consistent dividend growth, and strategic infrastructure investments. Key risks include rising debt levels (debt-to-asset ratio increased to 48.48% in 2025) and potential pressure from higher financing costs. The stock offers defensive value with a 3.29% dividend yield and exposure to growing data center demand in its service territories.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →About Alliant Energy Corporation
Alliant Energy is the parent of two regulated utilities, Interstate Power and Light and Wisconsin Power and Light, serving nearly 1 million electricity and natural gas customers and approximately 420,000 natural gas-only customers. Both subsidiaries engage in the generation and distribution of electricity and the distribution and transportation of natural gas. Alliant also owns a 16% interest in American Transmission Co.
Read more on LNT →
